Sign inGet started

Kaufmann Gunnar F.

Insider CIK 1786754 · ONCT Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ONCT Oncternal Therapeutics, In P Buy2023-06-142023-06-143,000$0.36 $1.1K94,726SEC↗
ONCT Oncternal Therapeutics, In P Buy2023-06-122023-06-1425,000$0.35 $8.8K91,726SEC↗
ONCT Oncternal Therapeutics, In A Award deriv2023-02-212023-02-23210,000— $0210,000SEC↗
ONCT Oncternal Therapeutics, In F Tax w/h2023-01-032023-01-056,266$1.02 $6.4K66,726SEC↗
ONCT Oncternal Therapeutics, In A Award deriv2022-07-282022-08-0128,750— $028,750SEC↗
ONCT Oncternal Therapeutics, In A Award2022-07-282022-08-0143,125— $072,992SEC↗
ONCT Oncternal Therapeutics, In A Award deriv2022-01-202022-01-24162,457— $0162,457SEC↗
ONCT Oncternal Therapeutics, In A Award2022-01-032022-01-0529,867— $029,867SEC↗
ONCT Oncternal Therapeutics, In A Award deriv2021-02-112021-02-16253,000— $0253,000SEC↗
ONCT Oncternal Therapeutics, In A Award deriv2020-03-172020-07-3114,260— $014,260SEC↗
ONCT Oncternal Therapeutics, In A Award deriv2020-03-172020-03-1814,260— $014,260SEC↗
ONCT Oncternal Therapeutics, In A Award deriv2019-09-052020-07-31150,000— $0150,000SEC↗
ONCT Oncternal Therapeutics, In A Award deriv2019-09-052019-09-09150,000— $0150,000SEC↗